![Jürgen Beck](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Jürgen Beck worked as Co-Managing Director at Paion Deutschland GmbH, Senior Vice President-Medical Affairs at Epigenomics AG, Vice President-Clinical & Medical Affairs at PROMETHERA Biosciences SA, and Vice President-Clinical Operations Europe at InterMune International AG.
He also served as Chief Development Officer at PAION AG from 2018 to 2020.
Beck holds an undergraduate and doctorate degree from Ruprecht-Karls-Universität Heidelberg, an undergraduate degree from Humboldt-Universität zu Berlin, and an MBA from the University of Hagen.
Ehemalige bekannte Positionen von Jürgen Beck
Unternehmen | Position | Ende |
---|---|---|
PAION AG | Corporate Officer/Principal | 31.12.2020 |
InterMune International AG | Corporate Officer/Principal | - |
Paion Deutschland GmbH
![]() Paion Deutschland GmbH BiotechnologyHealth Technology Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany. | Vorstandsvorsitzender | - |
PROMETHERA Biosciences SA
![]() PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Technik-/Wissenschafts-/F&E-Leiter | - |
EPIGENOMICS AG | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Jürgen Beck
Julius-Maximilians-Universität Würzburg | Undergraduate Degree |
Humboldt-Universität zu Berlin | Undergraduate Degree |
University of Hagen | Masters Business Admin |
Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
EPIGENOMICS AG | Health Technology |
PAION AG | Health Technology |
Private Unternehmen | 3 |
---|---|
PROMETHERA Biosciences SA
![]() PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Health Technology |
Paion Deutschland GmbH
![]() Paion Deutschland GmbH BiotechnologyHealth Technology Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany. | Health Technology |
InterMune International AG |